Geode Capital Management
SLS icon

Geode Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.82M Buy
2,200,428
+1,379,988
+168% +$3.02M ﹤0.01% 2752
2025
Q1
$886K Buy
820,440
+86,894
+12% +$93.9K ﹤0.01% 3347
2024
Q4
$763K Buy
733,546
+128,355
+21% +$134K ﹤0.01% 3461
2024
Q3
$757K Buy
605,191
+88,183
+17% +$110K ﹤0.01% 3454
2024
Q2
$615K Buy
517,008
+243,945
+89% +$290K ﹤0.01% 3491
2024
Q1
$276K Buy
273,063
+27,460
+11% +$27.7K ﹤0.01% 3827
2023
Q4
$260K Buy
245,603
+10,000
+4% +$10.6K ﹤0.01% 3849
2023
Q3
$387K Buy
235,603
+47,537
+25% +$78K ﹤0.01% 3697
2023
Q2
$295K Hold
188,066
﹤0.01% 3861
2023
Q1
$269K Hold
188,066
﹤0.01% 3907
2022
Q4
$443K Buy
188,066
+43,347
+30% +$102K ﹤0.01% 3717
2022
Q3
$292K Hold
144,719
﹤0.01% 4005
2022
Q2
$322K Buy
144,719
+7,823
+6% +$17.4K ﹤0.01% 3994
2022
Q1
$914K Buy
136,896
+3,095
+2% +$20.7K ﹤0.01% 3659
2021
Q4
$739K Hold
133,801
﹤0.01% 3855
2021
Q3
$1.23M Buy
133,801
+32,464
+32% +$297K ﹤0.01% 3580
2021
Q2
$1.12M Buy
101,337
+6,430
+7% +$71.3K ﹤0.01% 3530
2021
Q1
$810K Buy
94,907
+60,492
+176% +$516K ﹤0.01% 3644
2020
Q4
$199K Sell
34,415
-26,499
-44% -$153K ﹤0.01% 3887
2020
Q3
$161K Buy
60,914
+300
+0.5% +$793 ﹤0.01% 3782
2020
Q2
$177K Buy
60,614
+7,827
+15% +$22.9K ﹤0.01% 3697
2020
Q1
$91K Buy
52,787
+936
+2% +$1.61K ﹤0.01% 3800
2019
Q4
$222K Sell
51,851
-1,118,021
-96% -$4.79M ﹤0.01% 3758
2019
Q3
$141K Buy
1,169,872
+1,046,061
+845% +$126K ﹤0.01% 3876
2019
Q2
$13K Buy
123,811
+9,617
+8% +$1.01K ﹤0.01% 4182
2019
Q1
$116K Hold
114,194
﹤0.01% 3862
2018
Q4
$140K Buy
+114,194
New +$140K ﹤0.01% 3779
2017
Q4
Sell
-51,783
Closed -$18K 4038
2017
Q3
$18K Hold
51,783
﹤0.01% 4018
2017
Q2
$30K Sell
51,783
-50,915
-50% -$29.5K ﹤0.01% 4013
2017
Q1
$62K Buy
102,698
+32,307
+46% +$19.5K ﹤0.01% 3909
2016
Q4
$136K Buy
+70,391
New +$136K ﹤0.01% 3718